Folgen
Lee Rivera
Lee Rivera
Bestätigte E-Mail-Adresse bei ucsf.edu
Titel
Zitiert von
Zitiert von
Jahr
Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
E Allen, A Jabouille, LB Rivera, I Lodewijckx, R Missiaen, V Steri, K Feyen, ...
Science translational medicine 9 (385), eaak9679, 2017
6352017
Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy
LB Rivera, D Meyronet, V Hervieu, MJ Frederick, E Bergsland, G Bergers
Cell reports 11 (4), 577-591, 2015
1442015
Intertwined regulation of angiogenesis and immunity by myeloid cells
LB Rivera, G Bergers
Trends in immunology 36 (4), 240-249, 2015
1422015
Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma
SA Arnold, LB Rivera, AF Miller, JG Carbon, SP Dineen, Y Xie, ...
Disease Models & Mechanisms 3 (1-2), 57-72, 2010
1372010
The regulatory function of SPARC in vascular biology
LB Rivera, AD Bradshaw, RA Brekken
Cellular and Molecular Life Sciences 68, 3165-3173, 2011
1192011
Tumor angiogenesis, from foe to friend
LB Rivera, G Bergers
Science 349 (6249), 694-695, 2015
1162015
TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression
AF Hezel, V Deshpande, SM Zimmerman, G Contino, B Alagesan, ...
Cancer research 72 (18), 4840-4845, 2012
1072012
Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma
KY Aguilera, LB Rivera, H Hur, JG Carbon, JE Toombs, CD Goldstein, ...
Cancer research 74 (4), 1032-1044, 2014
1012014
SPARC promotes pericyte recruitment via inhibition of endoglin-dependent TGF-β1 activity
LB Rivera, RA Brekken
Journal of Cell Biology 193 (7), 1305-1319, 2011
962011
SPARC regulates collagen interaction with cardiac fibroblast cell surfaces
BS Harris, Y Zhang, L Card, LB Rivera, RA Brekken, AD Bradshaw
American Journal of Physiology-Heart and Circulatory Physiology 301 (3 …, 2011
852011
Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation
SA Arnold, LB Rivera, JG Carbon, JE Toombs, CL Chang, AD Bradshaw, ...
PloS one 7 (2), e31384, 2012
832012
Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis
KT Ostapoff, BK Cenik, M Wang, R Ye, X Xu, D Nugent, MM Hagopian, ...
Cancer research 74 (18), 4996-5007, 2014
782014
Location, location, location: macrophage positioning within tumors determines pro-or antitumor activity
LB Rivera, G Bergers
Cancer cell 24 (6), 687-689, 2013
542013
Rgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetes
A Villasenor, ZV Wang, LB Rivera, O Ocal, IW Asterholm, PE Scherer, ...
Disease Models & Mechanisms 3 (9-10), 567-580, 2010
462010
Targeting vascular sprouts
LB Rivera, G Bergers
Science 344 (6191), 1449-1450, 2014
322014
HR‐MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer
AS Wang, A Lodi, LB Rivera, JL Izquierdo‐Garcia, MA Firpo, SJ Mulvihill, ...
NMR in Biomedicine 27 (11), 1361-1370, 2014
312014
The fibronectin–ILT3 interaction functions as a stromal checkpoint that suppresses myeloid cells
KJ Paavola, JM Roda, VY Lin, P Chen, KP O'Hollaren, R Ventura, ...
Cancer immunology research 9 (11), 1283-1297, 2021
272021
Escape mechanisms from antiangiogenic therapy: an immune cell’s perspective
L Rivera, M Pandika, G Bergers
Tumor Microenvironment and Cellular Stress: Signaling, Metabolism, Imaging …, 2014
202014
Preclinical evaluation of NGM707, a novel anti-ILT2/anti-ILT4 dual antagonist monoclonal antibody
K Mondal, C Song, J Tian, C Ho, LB Rivera, J Huang, P Chen, S Crawley, ...
Cancer Res 81 (13), 13, 2021
92021
Woodchuck VEGF (wVEGF) characteristics: Model for angiogenesis and human hepatocellular carcinoma directed therapies
H Huang, O Salavaggione, L Rivera, S Mukherjee, R Brekken, B Tennant, ...
Archives of biochemistry and biophysics 661, 97-106, 2019
72019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20